| Title: | Identifying healthy individuals with Alzheimer's disease neuroimaging phenotypes in the UK Biobank |
| Journal: | Communications Medicine |
| Published: | 20 Jul 2023 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/37474615/ |
| DOI: | https://doi.org/10.1038/s43856-023-00313-w |
| URL: | https://www.nature.com/articles/s43856-023-00313-w.pdf |
Publication 11639
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundIdentifying prediagnostic neurodegenerative disease is a critical issue in neurodegenerative disease research, and Alzheimer's disease (AD) in particular, to identify populations suitable for preventive and early disease-modifying trials. Evidence from genetic and other studies suggests the neurodegeneration of Alzheimer's disease measured by brain atrophy starts many years before diagnosis, but it is unclear whether these changes can be used to reliably detect prediagnostic sporadic disease.MethodsWe trained a Bayesian machine learning neural network model to generate a neuroimaging phenotype and AD score representing the probability of AD using structural MRI data in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Cohort (cut-off 0.5, AUC 0.92, PPV 0.90, NPV 0.93). We go on to validate the model in an independent real-world dataset of the National Alzheimer's Coordinating Centre (AUC 0.74, PPV 0.65, NPV 0.80) and demonstrate the correlation of the AD-score with cognitive scores in those with an AD-score above 0.5. We then apply the model to a healthy population in the UK Biobank study to identify a cohort at risk for Alzheimer's disease.ResultsWe show that the cohort with a neuroimaging Alzheimer's phenotype has a cognitive profile in keeping with Alzheimer's disease, with strong evidence for poorer fluid intelligence, and some evidence of poorer numeric memory, reaction time, working memory, and prospective memory. We found some evidence in the AD-score positive cohort for modifiable risk factors of hypertension and smoking.ConclusionsThis approach demonstrates the feasibility of using AI methods to identify a potentially prediagnostic population at high risk for developing sporadic Alzheimer's disease.</p>
7 Authors
- Tiago Azevedo
- Richard A. I. Bethlehem
- David J. Whiteside
- Nol Swaddiwudhipong
- James B. Rowe
- Pietro Lió
- Timothy Rittman
Enabling scientific discoveries that improve human health